OutSMARTers program for kids with ADHD ages 9–12
Official title: The ADHD Kids´ Study: Randomized Clinical Trial on the OutSMARTers Program and Individual Counseling for Children Aged 9-12 With ADHD
Run by University of Iceland · NCT07379359 · Data updated 2026-11-12
This trial tests whether a group skills program called OutSMARTers helps 9–12 year-olds with ADHD compare to five weeks of individual counseling to see which improves communication, well-being, and emotional regulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 9 Years to 12 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Iceland Academic / other |
| Locations | 1 site (Reykjavik) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | October 1, 2028 |
| Study ends | October 1, 2029 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07379359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 9-12 with a confirmed ADHD diagnosis, fluent in Icelandic, and with IQ 70 or higher.
✕Probably not a fit
Children without a confirmed ADHD diagnosis, or those not meeting language or cognitive criteria, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares the OutSMARTers program, a CBT-based group skills training delivered over 10 sessions in 5 weeks, with five sessions of individual counseling (Kid Counseling Program) for children with ADHD aged 9–12. Approximately 100 participants will be randomized to either the OutSMARTers group or a wait-list control that receives the alternative intervention after a five-week delay. Outcomes will be measured using reports from parents, teachers, and the children themselves to assess communication skills, well-being, and emotional regulation. The study is conducted at the University of Iceland and associated centers, with eligibility requiring an ADHD diagnosis, fluency in Icelandic, and cognitive ability sufficient to participate. The aim is to determine whether a child-focused CBT skills program provides greater benefit than individualized counseling for core ADHD-related challenges.
Why it matters
Potential benefit: If successful, the OutSMARTers program could provide a more effective, scalable approach to improving emotional regulation and social skills for children with ADHD.
How similar studies have gone: Previous work suggests that CBT-based group interventions can help with emotional regulation and social skills in ADHD, but direct evidence in this age range with this specific program is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age: 9-12 * have an ADHD diagnosis confirmed by a school psychologist * children need to be fluent in Icelandic * Parents need to be fluent in Icelandic or English Exclusion Criteria: * Children need to have an IQ of 70 or higher (WISC-IV test or WPSSI-R test)
Where it's running
-
Children´s Mental Health Center / University of Iceland
Reykjavik, Iceland Recruiting
Study contacts
- Study coordinator: Dagmar Kr Hannesdottir, PhD
- Email: dkh@hi.is
- Phone: +354 525 4351
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Binaural Beats for Adults with ADHD
We’re testing whether a six-week program of music with embedded binaural beats helps adults with ADHD, compared to similar music without binaural beats.
-
Cannabigerol Oil for Adolescents With ADHD
This study tests full-spectrum cannabigerol (CBG) oil to see if it helps kids aged 12–17 who have ADHD and haven’t fully benefited from other treatments.
-
Treating ADHD in preschoolers: methylphenidate vs guanfacine
This study tests whether methylphenidate or guanfacine works better for kids ages 3–5 with ADHD.
-
Methylphenidate for attention and executive problems in children with sickle cell disease
This study will test whether once-daily extended-release methylphenidate for 4 weeks helps attention and thinking skills in children 8–17 with sickle cell disease while monitoring side effects and adherence.
-
Trying two forms of dexamfetamine sulfate for adults with ADHD and moderate-to-severe depression
This tests whether immediate-release and extended-release dexamfetamine sulfate can improve attention and depressive symptoms in adults with ADHD and moderate-to-severe major depression compared with placebo.
-
Trying new brain stimulation to help ADHD symptoms
This study tests whether theta burst repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex can reduce ADHD symptoms in children aged 9–15.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.